Small-Cap Momentum Watch: Upcoming Catalysts for May 11–15

From operational updates to conference participation, we’ve highlighted the small-cap events that could drive attention this week.

--

Companies Participating in the 21st Annual Needham Technology, Media & Consumer Conference

The 21st Annual Needham Technology, Media & Consumer Conference will take place May 12–14, 2026, with in-person sessions on May 12–13 at Needham & Company’s headquarters and a fully virtual format on May 14. The conference brings together public and private companies across technology, media, and consumer sectors for presentations, fireside chats, thematic panels, and one-on-one investor meetings.

Participating companies include:

DCGO • LAW • STEX • RBBN • DFDV • ALIT
RXRX • TBLA • RMNI • FATE • TLS

Companies Presenting at the 2026 ASGCT Annual Meeting

The 2026 ASGCT Annual Meeting will be held May 11–15, 2026, at the Thomas Michael Menino Convention & Exhibition Center in Boston, Massachusetts, with online participation options available. Hosted by the American Society of Gene & Cell Therapy, the meeting is one of the largest and most comprehensive events in the cell and gene therapy field, bringing together scientists, physicians, industry professionals, patient advocates, and innovators to share research, explore new technologies, and advance collaboration.

Participating companies include:

EDIT • FATE • GNPX • AZTR • TCRX • CLLS
SANA • VYGR • CABA • TNYA • INO • CLDI

Companies Participating in the BofA Securities 2026 Healthcare Conference

The BofA Securities 2026 Healthcare Conference will take place May 12–14, 2026, in Las Vegas, Nevada. The event brings together healthcare and biotechnology companies to present corporate strategies, clinical updates, financial outlooks, and market opportunities to investors and industry professionals.

Participating companies include:

CATX • BFLY • SANA • GERN • LUNG • EMBC
ABCL • MYGN • CRBU • NUVB • SGHT • ADGM
ACRS • ABOS • GUTS

Other companies with material events this week:

ALLR - announced that CEO Thomas Jensen will speak at Precision Medicine Forum Europe 2026 in Stockholm on May 11–12. Jensen’s oncology presentation, titled “Dual Inhibition of PARP and WNT: A Novel Drug-Biomarker Combination in Clinical Trials,” is scheduled for May 11 from 10:20–10:40 CEST and will focus on the Company’s clinical-stage oncology strategy and biomarker-driven approach.

CDXS - will present new ECO Synthesis® Manufacturing Platform data and regulatory engagement updates at TIDES USA 2026 in Boston, May 11–14. Presentations will highlight advances in phosphorothioate stereochemistry control, ligation efficiency, scalable RNA manufacturing, and sustainability in oligonucleotide production. Codexis will also host an expert panel discussion on stereochemistry in RNAi manufacturing featuring leaders from Alnylam, Arrowhead, and Codexis.

EDIT - will present at TIDES USA 2026, May 11–14, including an oral presentation titled “Transformative LDL Cholesterol Lowering In Vivo CRISPR Gene Editing Approach for Hyperlipidemia and Atherosclerotic Cardiovascular Disease” on May 13 from 8:30–9:00 a.m. EDT during the mRNA & Genome Editing session.

ZENA - announced that ZenaDrone will showcase its most comprehensive defense-focused presence to date at Xponential 2026, the flagship AUVSI conference taking place May 11–14 in Detroit, Michigan, highlighting the Company’s autonomous drone and defense solutions.

SCWO - announced participation in multiple environmental and water industry conferences in May, including WEF RBC in Kansas City, the NJWEA Annual Conference, and PFAS Forum VI in Orlando. 374Water will present on how its SCWO technology addresses PFAS-contaminated biosolids, stockpiled AFFF destruction, and waste management applications.

IPDN - announced that the TalentAlly Job Fair Platform is nearing launch and is expected to support the Company’s Minneapolis career fair on May 11, 2026, including registration and future virtual, in-person, and hybrid hiring events designed to expand employer and candidate engagement.

ATHE - will present data from its Multiple System Atrophy (MSA) program at two May medical conferences. At ISMRM/ISMRT 2026 in Cape Town, South Africa, Paula Trujillo, PhD, will deliver an oral presentation on progressive iron accumulation in early MSA on May 12, 2026, from 16:00–17:50 local time. At the MDSANZ Scientific Meeting in Sydney, Australia, Daniel Claassen, M.D., M.S., will present ATH434 Phase 2 data during the May 15–17, 2026 conference.

NAGE - announced that CFO Ozan Pamir will participate in the Emerging Company Pavilion at the 31st Annual Sohn Investment Conference on May 12, 2026, at Jazz at Lincoln Center in New York City.

ANVS - announced that CEO Maria Maccecchini will present at Fierce Biotech Week 2026 in Boston on May 13. Her presentation, “The Multi-Protein Reality of Alzheimer’s Disease,” will discuss the role of multiple neurotoxic proteins in Alzheimer’s progression and implications for future drug development.

USEG - announced participation in the inaugural Emerging Company Pavilion at the Sohn Investment Conference 2026 on May 12 in New York City, joining a select group of emerging companies presenting to institutional investors and family offices.

SKYX - announced it has been selected as one of only eight companies participating in the inaugural Emerging Company Pavilion at the Sohn Investment Conference 2026 on May 12 in New York City.

ZVIA - announced participation in two upcoming investor conferences. Zevia management will present at the Goldman Sachs Global Staples Forum on May 12 and the BMO Global Farm to Market Conference on May 14, while also conducting investor meetings.

WRAP - announced participation in a European law enforcement event in Italy on May 13–14 hosted by Defcon Services. The Company will showcase its BolaWrap®, WrapReality™, training programs, and broader non-lethal response ecosystem to law enforcement and government stakeholders.

LOCL - announced participation in the BMO Global Farm to Market Conference on May 13–14, where CEO Kathleen Valiasek and management will host investor meetings.

MOLN - announced participation at the 22nd Annual PEGS Boston conference, May 11–15, where the Company will present “Advancing Radio-DARPin therapeutics: from preclinical insights to clinical development” on May 13.

FBLG - announced presentation of preclinical CYPS317 psoriasis data at the Society for Investigative Dermatology 2026 Annual Meeting in Chicago, with the presentation scheduled for May 15.

PRZO - announced participation at the Black Sea Defense & Aerospace Exhibition (BSDA) in Bucharest, Romania, May 13–15, one of the leading defense and aerospace exhibitions in the Black Sea region involving NATO and regional defense organizations.

MYSZ - announced a growing strategic focus on the Asia-Pacific region and participation at LINK FASHION in Shanghai on May 13–14. The Company will present its AI-driven fashion technology platform focused on size accuracy, reducing returns, and inventory optimization.

MBOT - announced participation in the Global Embolization Symposium & Technologies (GEST) Conference in New York City from May 14–17, where the Company plans to expand awareness of its robotic interventional technologies and global commercialization efforts.

JRSH - announced that its board approved a quarterly cash dividend of $0.05 per share payable on or about May 21, 2026, to shareholders of record as of May 14, 2026.

EDAP - announced participation in the American Urological Association (AUA) Annual Meeting taking place May 15–18 in Washington, D.C.

ENGN - reported additional interim Phase 2 LEGEND trial data in BCG-unresponsive NMIBC patients treated with detalimogene, showing a 54% complete response rate at any time and 43% CR rate at six months, with low progression to muscle-invasive disease. The Company plans to present the data at the AUA meeting on May 15.

DOMH - announced that its board authorized a special cash dividend totaling approximately $9 million, or about $0.31 per share, payable on or about May 29, 2026, to shareholders and certain warrant holders of record as of May 15, 2026.

AIV - announced a $1.30 per share liquidating distribution payable June 3, 2026, to shareholders of record on May 15, funded by proceeds from recent asset sales. Due bill trading procedures will apply because the distribution exceeds 25% of the Company’s share price.

TARA - announced updated interim data from the ADVANCED-2 Phase 2 trial evaluating TARA-002 in BCG-naïve and BCG-unresponsive NMIBC patients will be presented at the AUA 2026 Annual Meeting on May 15 in Washington, D.C.

INN - announced a first quarter 2026 cash dividend of $0.08 per share and common unit, payable May 29, 2026, to holders of record as of May 15, 2026.

ANY - announced details regarding its proposed acquisition of Cathedra Bitcoin through a stock-for-stock transaction. Sphere shareholders will vote on multiple proposals related to the arrangement, board structure, incentive plan amendments, and a potential share consolidation at a special virtual meeting scheduled for May 15, 2026.

OLOX / VIVK - announced an amendment to their LOI for OLOX to acquire Vivakor subsidiary CPE Gathering MidCon and the Omega pipeline system. The targeted closing date has been revised to April 30, 2026, but no later than May 15, 2026. The approximately $36 million transaction includes cash, debt, and stock consideration.

LGPS - announced it has discontinued its share repurchase program and that the board is considering a special cash dividend using remaining authorized repurchase funds. A decision is expected at the May 15, 2026 board meeting.

PMAX - announced a non-binding LOI to acquire Boston Solar in a transaction valued at approximately $9 million, including assumption of debt. The parties expect to execute a definitive agreement by May 16, 2026, and Powell Max may provide up to $20 million in working capital following closing.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.